S. B. Zimmerman
- Co-authors
- E. O. StapleyDavid HendlinHiroshi ŌnishiSebastian HernandezSara CurrieS. MochalesJ.M. MataM. Jackson
- Topics
- Microbial Natural Products and Biosynthesis (8 papers)Phenothiazines and Benzothiazines Synthesis and Activities (5 papers)Synthesis and biological activity (2 papers)
- Journals
- Annals of the New York Academy of SciencesJournal of Medicinal ChemistryAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesJapanGermany
In The Last Decade
S. B. Zimmerman
18 papers receiving 474 citations
Peers
Comparison fields: 5 of 65
- Pharmacology 307
- Molecular Biology 268
- Molecular Medicine 161
- Organic Chemistry 137
- Plant Science 46
Countries citing papers authored by S. B. Zimmerman
This map shows the geographic impact of S. B. Zimmerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. B. Zimmerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. B. Zimmerman more than expected).
Fields of papers citing papers by S. B. Zimmerman
This network shows the impact of papers produced by S. B. Zimmerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. B. Zimmerman. The network helps show where S. B. Zimmerman may publish in the future.
Co-authorship network of co-authors of S. B. Zimmerman
This figure shows the co-authorship network connecting the top 25 collaborators of S. B. Zimmerman. A scholar is included among the top collaborators of S. B. Zimmerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. B. Zimmerman. S. B. Zimmerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | A roundtable discussion of antibiotic resistance: Putting the lessons to work | 6 |
| 3 | 32 | |
| 4 | 79 | |
| 5 | 3 | |
| 6 | 17 | |
| 7 | 13 | |
| 8 | 26 | |
| 9 | 35 | |
| 10 | 10 | |
| 11 | 4 | |
| 12 | 16 | |
| 13 | 5 | |
| 14 | 14 | |
| 15 | 12 | |
| 16 | 120 | |
| 17 | 126 | |
| 18 | 26 |
About S. B. Zimmerman
S. B. Zimmerman is a scholar working on Microbiology, Pharmacology and Applied Microbiology and Biotechnology, having authored 18 papers that have together received 546 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Molecular Medicine (161 citations), Pharmacology (307 citations) and Microbiology (8 citations). S. B. Zimmerman has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include E. O. Stapley, David Hendlin, Hiroshi Ōnishi, Sebastian Hernandez, Sara Currie, S. Mochales, J.M. Mata, M. Jackson, Richard L. Monaghan and H. B. Woodruff. Their work appears in journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.